{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:21:56Z","timestamp":1773296516917,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.expneurol.2008.05.015","type":"journal-article","created":{"date-parts":[[2008,5,31]],"date-time":"2008-05-31T08:05:05Z","timestamp":1212221105000},"page":"163-170","source":"Crossref","is-referenced-by-count":20,"title":["Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice"],"prefix":"10.1016","volume":"213","author":[{"given":"S.","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bizzoco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gianfriddo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Melani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pedata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2008.05.015_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0166-2236(00)01584-8","article-title":"Energetics in the pathogenesis of neurodegenerative diseases","volume":"23","author":"Beal","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/syn.890030106","article-title":"Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions","volume":"3","author":"Beal","year":"1989","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2008.05.015_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1474-4422(03)00411-3","article-title":"Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics","volume":"2","author":"Blum","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02260966","article-title":"NADPH-diaphorase\/nitric oxide synthase containing neurons in normal and Parkinson's disease putamen","volume":"7","author":"Bockelmann","year":"1994","journal-title":"J. Neural. Transm. Park Dis. Dement. Sect."},{"key":"10.1016\/j.expneurol.2008.05.015_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1098\/rstb.1999.0449","article-title":"Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease","volume":"354","author":"Cha","year":"1999","journal-title":"Philos. Trans. R. Soc. Lond B Biol. Sci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib7","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2008.05.015_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/exnr.1994.1064","article-title":"Cerebellar injury induces NADPH diaphorase in Purkinje and inferior olivary neurons in the rat","volume":"126","author":"Chen","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib9","doi-asserted-by":"crossref","first-page":"14331","DOI":"10.1074\/jbc.M413279200","article-title":"cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues","volume":"280","author":"Chiang","year":"2005","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.expneurol.2008.05.015_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","article-title":"CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model","volume":"93","author":"Chou","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0006-8993(96)00307-1","article-title":"Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease","volume":"730","author":"Cicchetti","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0028-3908(94)90045-0","article-title":"Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures","volume":"33","author":"Dawson","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2008.05.015_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-8993(01)03000-1","article-title":"Reduced activity and protein expression of NOS in R6\/2 HD transgenic mice: effects of L-NAME on symptom progression","volume":"919","author":"Deckel","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(02)02550-7","article-title":"Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice","volume":"939","author":"Deckel","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nbd.2007.07.009","article-title":"Behavioral and electrophysiological effects of the adenosine A(2A) receptor antagonist SCH 58261 in R6\/2 Huntington's disease mice","volume":"28","author":"Domenici","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.05.015_bib17","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.0953-816x.2001.01771.x","article-title":"In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261","volume":"14","author":"El Yacoubi","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2008.05.015_bib19","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.88.16.7238","article-title":"Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes","volume":"88","author":"Ferre","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2008.05.015_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1471-4159.2003.02145.x","article-title":"Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage","volume":"88","author":"Fink","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1460-9568.2003.02844.x","article-title":"Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain","volume":"18","author":"Fusco","year":"2003","journal-title":"Eur. J Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)10102-9","article-title":"Effect of K+ channel modulation on mouse feeding behaviour","volume":"329","author":"Ghelardini","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2004.05.008","article-title":"Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow","volume":"17","author":"Gianfriddo","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.05.015_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.05.015_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1749-6632.1999.tb07827.x","article-title":"Bioenergetics in Huntington's disease","volume":"893","author":"Grunewald","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib26","first-page":"309","article-title":"Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum","volume":"50","author":"Harrington","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1471-4159.1998.71010088.x","article-title":"Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha\/lipopolysaccharide","volume":"71","author":"Heneka","year":"1998","journal-title":"J Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/1096-9861(20010312)431:3<331::AID-CNE1074>3.0.CO;2-W","article-title":"Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum","volume":"431","author":"Hettinger","year":"2001","journal-title":"J. Comp Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3940(89)90048-7","article-title":"Striosomes and extrastriosomal matrix contain different amounts of immunoreactive choline acetyltransferase in the human striatum","volume":"96","author":"Hirsch","year":"1989","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2008.05.015_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0306-4522(03)00482-2","article-title":"Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide","volume":"121","author":"Hortobagyi","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.05.015_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0166-2236(96)10074-6","article-title":"Bright and dark sides of nitric oxide in ischemic brain injury","volume":"20","author":"Iadecola","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/jcbfm.1995.6","article-title":"Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia","volume":"15","author":"Iadecola","year":"1995","journal-title":"J Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2008.05.015_bib33","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1523\/JNEUROSCI.17-23-09157.1997","article-title":"Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene","volume":"17","author":"Iadecola","year":"1997","journal-title":"J Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-2999(89)90571-2","article-title":"Direct autoradiographic localization of adenosine A2 receptors in the rat brain using the A2-selective agonist, [3H]CGS 21680","volume":"168","author":"Jarvis","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1403.009","article-title":"Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity","volume":"1122","author":"Lipsky","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib37","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/glia.10261","article-title":"Microglia density decreases with age in a mouse model of Huntington's disease","volume":"43","author":"Ma","year":"2003","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2008.05.015_bib39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2008.05.015_bib40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(02)03753-8","article-title":"The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat","volume":"959","author":"Melani","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib41","unstructured":"Melani, A., Gianfriddo, M., Vannucchi, M.G., Cipriani, S., Baraldi, P.G., Giovannini, M.G., Pedata, F., 2006. The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 1073\u20131074, 470\u2013480."},{"key":"10.1016\/j.expneurol.2008.05.015_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(24)37372-0","article-title":"Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat","volume":"285","author":"Monopoli","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2008.05.015_bib43","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.95.18.10966","article-title":"Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia","volume":"95","author":"Nogawa","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2008.05.015_bib44","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0306-4522(95)00596-X","article-title":"Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease","volume":"72","author":"Norris","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.05.015_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1179\/016164105X21913","article-title":"The protective effect of adenosine A2A receptor antagonism in cerebral ischemia","volume":"27","author":"Pedata","year":"2005","journal-title":"Neurol. Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)03102-5","article-title":"Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation","volume":"951","author":"Perez-Severiano","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1471-4159.2003.02306.x","article-title":"Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors","volume":"89","author":"Pintor","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pneurobio.2006.12.005","article-title":"Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease","volume":"81","author":"Popoli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/1568015043477577","article-title":"The controversial role of adenosine A2A receptor antagonists as neuroprotective agents","volume":"4","author":"Popoli","year":"2004","journal-title":"Curr. Med. Chem - Central Nervous System Agents"},{"key":"10.1016\/j.expneurol.2008.05.015_bib50","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1523\/JNEUROSCI.22-05-01967.2002","article-title":"Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum","volume":"22","author":"Popoli","year":"2002","journal-title":"J Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib51","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2008.05.015_bib52","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3171\/jns.1977.47.4.0577","article-title":"Objective clinical assessment of motor function after experimental spinal cord injury in the rat","volume":"47","author":"Rivlin","year":"1977","journal-title":"J.Neurosurg."},{"key":"10.1016\/j.expneurol.2008.05.015_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib54","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1991.tb08257.x","article-title":"Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study","volume":"57","author":"Schiffmann","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.05.015_bib55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/exnr.1999.7218","article-title":"Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD- and NO-mediated neuroprotection","volume":"160","author":"Shen","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington's disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2008.05.015_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01795308","article-title":"Lectin binding by resting and reactive microglia","volume":"16","author":"Streit","year":"1987","journal-title":"J Neurocytol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2006.01.014","article-title":"Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease","volume":"23","author":"Tarditi","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.05.015_bib60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2008.05.015_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00684399","article-title":"The solitary active cells. histochemical demonstration of damage-resistant nerve cells with a TPN-diaphorase reaction","volume":"3","author":"Thomas","year":"1964","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib62","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2008.05.015_bib63","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ana.410270606","article-title":"Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum","volume":"27","author":"Uemura","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2006.11.029","article-title":"Relationships between neurons expressing neuronal nitric oxide synthase, degree of microglia activation and animal survival. A study in the rat cortex after transient ischemia","volume":"1132","author":"Vannucchi","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.05.015_bib65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuroscience.2005.08.044","article-title":"Expression of neuronal and inducible nitric oxide synthase in neuronal and glial cells after transient occlusion of the middle cerebral artery","volume":"136","author":"Vannucchi","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.05.015_bib66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.00-0730fje","article-title":"Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin","volume":"15","author":"Varani","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2008.05.015_bib67","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","article-title":"Aberrant A2A receptor function in peripheral blood cells in Huntington's disease","volume":"17","author":"Varani","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.expneurol.2008.05.015_bib68","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0301-0082(00)00056-3","article-title":"Arginine metabolism and the synthesis of nitric oxide in the nervous system","volume":"64","author":"Wiesinger","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2008.05.015_bib69","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0306-4522(94)90394-8","article-title":"Neuronal nitric oxide synthase is induced in spinal cord neurones by traumatic injury","volume":"61","author":"Wu","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.05.015_bib70","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(94)90958-X","article-title":"Expression of c-jun and neuronal nitric oxide synthase in rat spinal motoneurons following axonal injury","volume":"179","author":"Wu","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2008.05.015_bib71","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1460-9568.1999.00567.x","article-title":"Mutual regulation between the intercellular messengers nitric oxide and brain-derived neurotrophic factor in rodent neocortical neurons","volume":"11","author":"Xiong","year":"1999","journal-title":"Eur. J Neurosci."},{"key":"10.1016\/j.expneurol.2008.05.015_bib72","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/01.STR.24.12.2016","article-title":"Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats","volume":"24","author":"Zhang","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2008.05.015_bib73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2008.05.015_bib74","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2008.05.015_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol Genet."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608002276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608002276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T14:23:03Z","timestamp":1738246983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608002276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0014488608002276"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.05.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}